3rd Quarter - Report

JENNINGS POLICY STRATEGIES for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Average Manufacturers Price/AMP including H.R. 6331 Any matters relating to access to generic drugs

LobbyistCovered position, as disclosed
KATHERINE HAYES HEALTH COUNSEL, US SENATOR EVAN B AYH
CHRISTOPHER JENNINGS —

Contacted: Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6331 (110th)

Pharmacy PHA

Advocate for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including but not limited to H.R. 1038, S. 623, H.R. 5629, H.R. 1956, S. 1505, S. 1695). Food and Drug Administration Amendents Act of 2007 (H.R. 3580) Citizens Petitions, including but not limited to S. 25 and S. 1080 Counterfeit Drugs/Import safety/Pedigree Electronic prescribing (including H.R. 6331, S. 2408, and H.R. 4296) Prescription drug importation/re-importation Average Manufacturers Price/AMP

LobbyistCovered position, as disclosed
KATHERINE HAYES HEALTH COUNSEL, US SENATOR EVAN BAYH
CHRISTOPHER JENNINGS —

Contacted: SENATE; Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES

Bills named: S. 2408 (110th), H.R. 3580 (110th), H.R. 1956 (110th), H.R. 6331 (110th), H.R. 1038 (110th), S. 623 (110th), S. 1505 (110th), S. 1695 (110th), H.R. 4296 (110th), H.R. 5629 (110th), S. 1080 (110th), S. 25 (110th)

Health Issues HCR

Advocate for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including but not limited to H.R. 1038, S. 623, H.R. 5629, H.R. 1956, S. 1505, S. 1695). Food and Drug Administration Amendents Act of 2007 (H.R. 3580) Citizens Petitions, including but not limited to S. 25 and S. 1080 Counterfeit Drugs/Import safety/Pedigree Electronic prescribing (including H.R. 6331, S. 2408, and H.R. 4296) Prescription drug importation/re-importation Average Manufacturers Price/AMP

LobbyistCovered position, as disclosed
KATHERINE HAYES HEALTH COUNSEL, US SENATOR EVAN BAYH
CHRISTOPHER JENNINGS —

Contacted: Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2408 (110th), S. 1695 (110th), S. 623 (110th), H.R. 4296 (110th), S. 1080 (110th), S. 25 (110th), H.R. 5629 (110th), H.R. 6331 (110th), S. 1505 (110th), H.R. 1038 (110th), H.R. 1956 (110th), H.R. 3580 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.